Bioventus
BVS
71 hedge funds and large institutions have $33.6M invested in Bioventus in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 27 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.13% less ownership
Funds ownership: 50.59% → 50.46% (-0.13%)
15% less funds holding
Funds holding: 84 → 71 (-13)
48% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 27
56% less call options, than puts
Call options by funds: $7K | Put options by funds: $16K
59% less capital invested
Capital invested by funds: $81.8M → $33.6M (-$48.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.84M |
| 2 |
Millennium Management
New York
|
+$1.9M |
| 3 |
SO
STRS Ohio
Columbus,
Ohio
|
+$535K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$295K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$289K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$3.59M |
| 2 |
JFG
Jefferies Financial Group
New York
|
-$1.47M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$1.4M |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$690K |
| 5 |
BlackRock
New York
|
-$509K |
BVS Hedge Fund Activity: Q1 2023 in Review
71 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q1 2023, worth a combined $33.6M — down 59% from $81.8M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of BVS and 14 opened new positions — a net loss of 13 holders — while 22 trimmed existing stakes and 27 added.
The largest buyer was Nantahala Capital Management, adding an estimated $3.84M. The largest seller was First Light Asset Management, exiting entirely with an estimated $3.59M sold.
- 71 institutional investors held Bioventus (BVS) as of Q1 2023, down from 84 in Q4 2022.
- Funds reported $33.6M of Bioventus stock for Q1 2023, down 59% quarter-over-quarter.
- 14 funds opened new Bioventus positions in Q1 2023 and 27 closed out, a net change of -13 holders.
- The largest Bioventus buyer in Q1 2023 was Nantahala Capital Management, an estimated $3.84M added.
- The largest Bioventus seller in Q1 2023 was First Light Asset Management, an estimated $3.59M sold.
Based on aggregated 13F filings for Q1 2023.